April 2022 FDA Recall Drug by Akorn, Inc.
D-0846-2022 - Failed viscosity specification - product was below specificcation

This Class III drug recall was voluntarily initiated by Akorn, Inc. on April 15, 2022 for the product Drug. The FDA reported the reason for recall as failed viscosity specification - product was below specificcation. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0846-2022

Reason for Recall
Failed viscosity specification - product was below specificcation
Initiated
04-15-2022
Reported
05-11-2022
Quantity
66,744 bottles

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
89993
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Akorn, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide USA and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
09-28-2023
Product Description About Product Description
Full technical description of the product.
Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2%, 100 mL per bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701, NDC 50383-775-04

Batch or Lot Expiration Information

Lot# : 370978, Exp 9/30/2022